arrow
T

Tanzila Rahman

Gilead Sciences
H指数:5
被引数:151
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CBX250 Is a Novel Cathepsin G Peptide-HLA-Targeting T Cell Engager That Exhibits High Tumor Antigen and Potent Antileukemic In Vivo

CBX250是一种新型组织蛋白酶G肽-HLA靶向的T细胞结合剂,具有高肿瘤抗原性并在体内表现出强大的抗白血病活性。

BLOOD
IF23.1
2024-11-050
PRE
Characterization of CBX-250, a first-in-class TCR-mimetic-based T-cell engager targeting a cathepsin G peptide-HLA complex for the treatment of myeloid leukemia
2024-03-221
PRE
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
2023-02-1014
OA
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody
2022-11-0415
OA